Limitations, agreements, and source contact

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors · Source last updated 2024-06-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

OTHER

restrictive Agreement

true

point Of Contact

email

Yvan.LeBruchec@adctherapeutics.com

organization

ADC Therapeutics

phone

+41799110551

title

Yvan LeBruchec

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice